Received: 19 November 2018
Accepted: 28 August 2019
First Online: 6 September 2019
Ethics approval and consent to participate
: The research protocol was approved by the Clinical Research Ethics Committee at General Hospital of Valencia (Spain) (authorisation number JUA-FAR-2015-01) prior to commencing the study.All participants expressed their consent to participate in the study. Our research worked with three different population samples. In phase 1 the participants gave their written informed consent to participate in the study. In phase 2, discussion group, before starting the session, the participants were duly informed and expressed their verbal consent to participate, which was recorded along with the content of the conversation held. Finally, in phase 3, after the participants were rightly informed (verbal and written information), they gave their consent to participate by agreeing to respond and deliver the questionnaire freely, voluntarily and anonymously. In addition, the anonymity of the participants is guaranteed at all times.
: Not applicable.
: The authors declare that they have no competing interests.